The trial in the November 13 attacks is set to resume on Tuesday in the Special Aid Court in Paris after a two-week hiatus, but will depend on the health of Salah Abdeslam, the main defendant who tested positive for the Covit-19 on December 27. The trial is set to resume on Tuesday at 12:30 p.m.
“Considering the various interpretations given by the prison authorities based on the length of time I spent in solitary confinement in detention during the positive test for Govt’s disease and the results of Salah’s medical expertise and the results of the new information I have received. …) Debates can usually resume on “, Chairman Assis Jean-Louis Perius.
On Friday, Mr. Perius set January 13 for the resumption of discussions.
But, since Monday, the isolation period has changed in the event of a positive govt test.
“If Salah Abdeslam is positive, we will wait until he turns negative,” said a source familiar with the AFP’s question on Monday.
The only survivor of jihadist commandos that killed 130 people in Paris and Saint-Denis in November 2015 and wounded hundreds, Salah Abdeslam, who has not been on trial since November 25, tested positive for Kovit-19 on December 27.
Abdeslam is imprisoned in the Fleury-Mérogis (Essonne) prison south of Paris. Several sources of pollution have recently been discovered there. However, in solitary confinement, the prisoner is not in a bubble. He can get his lawyers and work with supervisors on a daily basis.
Twenty defendants, including fourteen who were tried by the Special Aid Court from September 8 to the end of May, are suspected of being involved on various levels in preparing for the deadliest jihadist attacks ever carried out in France.
Defendants are due to be arraigned Tuesday. This adjournment will disrupt the planning of the trial. Salah Abdeslam’s trial was originally scheduled for January 13 and 14.
The epidemic has already disrupted trials in France, similar to the Charlie Hebdo and Hypercatcher attacks in 2020, which had to be interrupted for a month in the fall of 2020 after three cases of contamination among the accused.
Currently, clusters have been identified in many French prisons, especially in Perpignan. Nationwide, 370 of the approximately 70,000 inmates were found to be polluted, and 448 among the staff (approximately 40,000), according to a December 27 report by the Ministry of Justice.